Guideline on Active Substance Master File Procedure
the active substance and its use in the medicinal product needs to be justified in this MAA or MAV. Although the ASMF procedure is developed to keep intellectu al property of the ASM confidential, it is also permissible to use the procedure when there is no confidentiality issue between the Applicant/MA . 1.
Download Guideline on Active Substance Master File Procedure
Information
Domain:
Source:
Link to this page:
Documents from same domain
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Related documents
Active and Passive Remote Sensing - University of Rhode …
www.edc.uri.eduActive microwave (RADAR= RAdio Detection and Ranging), which is based on the transmission of long-wavelength microwave (e.g., 3-25 cm) through the atmosphere and then ... penetrate into a dry substance is that the penetration should be equal to the wavelength of the radar system. However,, active microwave energy may penetrate extremely
Substance Abuse Aftercare Treatment - Arizona State …
cabhp.asu.edu´In fact, up to 65.5% of people with a substance dependence disorder had at least one mental disorder and 51% of people with a mental disorder had at least one substance abuse disorder. ´We are also increasingly learning that these poorer outcomes result as much from these separate and contradictory systems of care as from the diagnoses
Rhode Island Board of Nurse Registration and Nursing …
health.ri.govCopy of Active RN license in Rhode Island Letter of APRN certification from professional certifying organization. National Criminal Background check supported by fingerprints. This report MUST be sent directly from the De- ... Controlled Substance Registration (CSR) and a Drug Enforcement Administration (DEA) Registration.
Credentialed Alcoholism and Substance Abuse Counselor: …
oasas.ny.govYour CASAC Application will remain active for a period of five years from the postmark date. A CASAC Trainee certificate ... to the Knowledge of Substance Use Disorders (Section I) and 15 clock hours of education and /or training related to Ethics for Addictions Professionals (Section IV). Completion of these requirements, however, will
Drug Fact Sheet: Marijuana/Cannabis - DEA
www.dea.govWhen marijuana is smoked, the active ingredient THC passes from the lungs and into the bloodstream, which carries the chemical to the organs throughout the body, including the brain. ... Marijuana is a Schedule I substance under the Controlled Substances Act, meaning that it has a high potential for abuse, no currently accepted
active substance, excipient and primary container …
www.ema.europa.euuse (e.g. difficulties to differentiate between starting material, active substance and finished product in some cases, scarcity of starting materials/active substance/finished product (autologous products and matched-donor scenario), small volumes of production). The level of documentation that is expected to
2018 National Survey on Drug Use and Health: African …
www.samhsa.govsubstance use disorders, mental health, and the receipt of treatment services for these disorders in the United States. ... • Excludes: Active military, long -term hospital residents, prison populations, homeless not in shelters • Sample includes all 50 states and DC
Peers Supporting Recovery from Substance Use Disorders
www.samhsa.govsubstance use treatment without other recovery supports has often not been sufficient in helping individuals to maintain long-term recovery. Substance use disorders are currently understood to be chronic conditions that require long-term management, like diabetes. Peer-based recovery support provides a range of person-centered and